Stay updated on TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial

Sign up to get notified when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added new study identifiers KEYNOTE-E10, MK-3475-E10, and jRCT2061220066; removed MK3475-C73 and updated the registry labeling.
    Difference
    0.1%
    Check dated 2026-03-25T20:27:48.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing v3.4.2 in the page's release notes.
    Difference
    0.0%
    Check dated 2026-03-11T14:25:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added detailed primary objectives (PFS/OS) and endpoint definitions (ORR, DoR, DCR, PFS, OS) along with TROP2 NMR assessment and IPD data-sharing information. Removed or altered several earlier endpoint definitions, time frames, and explicit eligibility criteria.
    Difference
    0.7%
    Check dated 2026-02-24T09:21:13.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T01:22:54.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1 and the government funding notice and Revision: v3.4.0 have been removed.
    Difference
    0.1%
    Check dated 2026-02-09T22:52:51.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Site-wide notice informs users that information may not be up to date due to a lapse in government funding and that the NIH Clinical Center is open, with operating-status updates linked. This change does not affect the study content, eligibility criteria, or trial results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-02T21:02:41.000Z thumbnail image

Stay in the know with updates to TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.